Skip to main content
Earnings Labs
Cartesian Therapeutics, Inc. logo

Cartesian Therapeutics, Inc. (RNAC)

NASDAQ·Healthcare·Biotechnology

$7.39

-3.40%

Mkt Cap $299.10M

Analyst Ratings

Buy

10

Hold

0

Sell

0

Price Target (5 analysts)

$20.50

Range $16.00$25.00

Implied Upside

+177.4%

Consensus $20.50 vs current $7.39